Effect of Plantago major on wound healing
Phase 3
Recruiting
- Conditions
- Condition 1: Diabetic Foot Ulcer. Condition 2: Bedsore.Type 2 diabetes mellitus with foot ulcerPressure ulcerE11.621
- Registration Number
- IRCT20150721023282N12
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Diabetic foot ulcer grade 1 or 2
Bedsore stage 2 or 3
Exclusion Criteria
Smoking
Use of Anticoagulant Drugs Within the Last 3 Months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percent of Decrease in Ulcer Size. Timepoint: Baseline, 7 and 14 Days after Initiation of Intervention. Method of measurement: Ruler.;The Number of Cases of Complete Ulcer Healing. Timepoint: During the Intervention. Method of measurement: Observation.
- Secondary Outcome Measures
Name Time Method The Number of Cases with Peri-Ulcer Erythema. Timepoint: Baseline, 7 and 14 Days after Initiation of Intervention. Method of measurement: Observation.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does Plantago major extract modulate to promote wound healing in diabetic foot ulcers and pressure ulcers?
How does Plantago major extract compare to standard-of-care treatments like growth factors or silver-based dressings in accelerating diabetic foot ulcer and pressure ulcer healing?
Which biomarkers, such as HbA1c or inflammatory cytokines, predict response to Plantago major extract in diabetic foot ulcer and pressure ulcer patients?
What are the known or potential adverse events and management strategies for Plantago major extract in diabetic foot ulcer and pressure ulcer treatment?
Are there synergistic effects when combining Plantago major extract with aloe vera or recombinant human epidermal growth factor in diabetic foot ulcer and pressure ulcer management?